---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-122823"
form_type: "8-K"
ticker: "LAB"
cik: "0001162194"
company_name: "STANDARD BIOTOOLS INC."
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:18:12.587624+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Standard BioTools appoints Alex Kim as CFO; COO role eliminated

## Summary
- Alex Kim appointed full-time CFO effective Nov 11, 2024; was interim CFO since Sept 1, 2024.
- Kim previously served as COO; that position will be vacated after his CFO appointment.
- Kim is a co-founder with nearly 30 years experience in healthcare and life sciences.
- Jonathan Mickelsen named VP & Chief Accounting Officer.
- No additional compensation for Kim in CFO role.

## SEC filing metadata
- accession: 0000950170-24-122823
- form_type: 8-K
- ticker: LAB
- cik: 0001162194
- company_name: STANDARD BIOTOOLS INC.
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1162194/000095017024122823/0000950170-24-122823-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1162194/000095017024122823/lab-20241106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-122823
- JSON: https://secwatch.observer/filing/0000950170-24-122823.json
- Plain text: https://secwatch.observer/filing/0000950170-24-122823.txt

## Key facts
- Executive change
  Alex Kim was appointed as Chief Financial Officer at STANDARD BIOTOOLS INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On November 6, 2024, the Board of Directors of Standard BioTools Inc. (the “Company”) appointed Alex Kim, who has been serving as the Company’s Interim Chief Financial Officer since September 1, 2024, as the Company’s fulltime Chief Financial Officer, effective as of November 11, 2024 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000095017024122823/0000950170-24-122823-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.